About this trial
The purpose of this study is to find out whether a mobile app called the ExerciseRx app is a practical and helpful way for people with axial spondyloarthritis (axSpA) to receive exercise recommendations as part of their regular rheumatology care.
Researchers want to learn:
Whether people with axSpA find the ExerciseRx app easy to use and helpful for supporting regular exercise.
Whether using the ExerciseRx app leads to improvements in symptoms, physical function, and disease activity compared with usual care.
Participants assigned to the ExerciseRx group will use the app to complete guided exercises for 20-30 minutes, four times per week. They will also receive personalized weekly step-count goals to help increase their physical activity. Researchers will compare outcomes between participants using the app and those receiving usual care.
Eligibility criteria
Qualifiers
Diagnosis of axial spondyloarthritis by a rheumatologist
English speaking
Insufficiently active (less than 150 minutes of moderate intensity aerobic activity per week)
Willing to wear a Fitbit for the study duration
Disqualifiers
Currently pregnant
International travel or any circumstance causing lack of access to wi-fi/Internet at any point during the study period
Recent or planned surgery that may affect ability to engage in physical activity
Unable to exercise for health reasons, or a provider has recommended against exercising for safety/health reasons
Trial design
Treatments tested in this trial
- Physical activity program intervention
- Usual Care Group
Treatment groups
Sponsors and collaborators
University of Washington
Lead sponsor
Arthritis Foundation
Collaborator